Approval · Notice of Compliance 37375 · 2026
ZENHALE: Notice of Compliance 37375
Issued April 21, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37375
- Date
- April 21, 2026
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of a primary container closure system
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZENHALE | Not yet assigned | — |
Medicinal ingredients
- MOMETASONE FUROATE 0.1 MG per ACT
- FORMOTEROL FUMARATE DIHYDRATE 0.005 MG per ACT
- MOMETASONE FUROATE 0.2 MG per ACT